Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Neuroblastoma 2018 NCI 5P30CA014089-43 5251 Core-009 FARNHAM, PEGGY UNIVERSITY OF SOUTHERN CALIFORNIA CA $649,099
Neuroblastoma 2018 NCI 5P30CA014089-43 8290 Tumor Microenvironment Research Program (Project-003) DECLERCK, YVES UNIVERSITY OF SOUTHERN CALIFORNIA CA $70,375
Neuroblastoma 2018 NCI 5R01CA211328-02 Regulation of the LIN28/let-7 pathway in cancer GREGORY, RICHARD BOSTON CHILDREN'S HOSPITAL MA $404,888
Neuroblastoma 2018 NCI 5R01CA204093-02 A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma PANDIT-TASKAR, NEETA SLOAN-KETTERING INST CAN RESEARCH NY $392,078
Neuroblastoma 2018 NCI 5P30CA008748-52 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $206,346
Neuroblastoma 2018 NINDS 5R01NS094218-02 Focal Sustained Release Chemotherapy-Loaded Biomaterials at Tumor Sites KAPLAN, DAVID TUFTS UNIVERSITY MEDFORD MA $342,745
Neuroblastoma 2018 NCI 1R01CA221957-01 Genomic and functional characterization of a panel of neuroblastoma patient-derived xenografts and cell lines REYNOLDS, CHARLES TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $553,437
Neuroblastoma 2018 NCI 5K08CA194162-04 The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas SCHNEPP, ROBERT EMORY UNIVERSITY GA $168,264
Neuroblastoma 2018 NCI 5R01CA197336-03 Transcriptional CDKs as therapeutic targets in MYC-dependent cancers GEORGE, RANI DANA-FARBER CANCER INST MA $407,748
Neuroblastoma 2018 NCI 5U10CA180884-05 COG NCTN Solid Malignancy Integrated Translational Science Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $192,024
Neuroblastoma 2018 NCI 5P30CA021765-39 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $256,190
Neuroblastoma 2018 NCI 1R01CA215651-01A1 Dual PI3K/BRD4 inhibitory chemotype for maximum inhibition of Myc and cancer DURDEN, DONALD UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $509,469
Neuroblastoma 2018 NCI 5R01CA180692-04 Role of LMO1 in Neuroblastoma Initiation and Maintenance MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $606,838
Neuroblastoma 2018 NCI 5R01CA148688-07 The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma GEORGE, RANI DANA-FARBER CANCER INST MA $413,844
Neuroblastoma 2018 NINDS 5R01NS088355-04 Targeting BET-bromodomains in neuroblastoma WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $651,177
Neuroblastoma 2018 NIDDK 5R01DK061470-15 Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma CHUNG, DAI VANDERBILT UNIVERSITY MEDICAL CENTER TN $409,278
Neuroblastoma 2018 NCI 5R01CA215452-02 Identifying and targeting oncogenic Myc enhancer control in pediatric tumors LIN, CHARLES BAYLOR COLLEGE OF MEDICINE TX $362,569
Neuroblastoma 2018 NCI 5R01CA215610-02 ABT-199 based therapies to treat neuroblastoma FABER, ANTHONY VIRGINIA COMMONWEALTH UNIVERSITY VA $359,846
Neuroblastoma 2018 NCI 1R01CA219024-01A1 Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance. FABBRI, MULLER CHILDREN'S HOSPITAL OF LOS ANGELES CA $123,772
Neuroblastoma 2018 NCI 1U01CA224766-01 Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers HEDRICK, CATHERINE LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $418,320
Neuroblastoma 2018 NIGMS 5R01GM117014-03 TRPM2, Mitochondria, and Cell Survival MILLER, BARBARA PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $297,883
Neuroblastoma 2018 NCI 5R01CA193890-04 HAUSP inhibitors in p53-wild type and p53-mutant tumors GU, WEI COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Neuroblastoma 2018 NCI 5R01CA140198-10 Targeting Oncogenic ALK Signaling in Neuroblastoma MOSSE, YAEL CHILDREN'S HOSP OF PHILADELPHIA PA $374,304
Neuroblastoma 2018 NCI 5R01CA174808-06 Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells SHOHET, JASON UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $347,563
Neuroblastoma 2018 NCI 5R01CA116548-13 THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA METELITSA, LEONID BAYLOR COLLEGE OF MEDICINE TX $249,638
Neuroblastoma 2018 NCI 1K08CA226237-01 Elucidating transcription regulation by epigenetics in neuroblastoma APPLEBAUM, MARK UNIVERSITY OF CHICAGO IL $206,394
Neuroblastoma 2018 NIDCD 5K23DC014291-03 Prevention of Cisplatin-induced Hearing Loss in Children with Cancer ORGEL, ETAN CHILDREN'S HOSPITAL OF LOS ANGELES CA $194,011
Neuroblastoma 2018 NCI 1R21CA226959-01 Eradication of MYCN-amplified neuroblastoma by targeting the interaction between a long noncoding RNA and its binding protein LIU, TAO UNIVERSITY OF NEW SOUTH WALES AUSTRA $124,967
Neuroblastoma 2018 NCI 5R01CA057138-27 Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $635,460
Neuroblastoma 2018 NCI 5R01CA204974-03 Structural Variation in Neuroblastoma DISKIN, SHARON CHILDREN'S HOSP OF PHILADELPHIA PA $384,300
Neuroblastoma 2018 NCI 5R01CA197964-04 Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor KITLINSKA, JOANNA GEORGETOWN UNIVERSITY DC $352,710
Neuroblastoma 2018 NCI 5U01CA199287-04 Pediatric Preclinical Testing Consortium MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $357,000
Neuroblastoma 2018 NCI 5R01CA197903-03 Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma ZHONG, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $378,357
Neuroblastoma 2018 NCI 5P30CA093373-16 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $284,088
Neuroblastoma 2018 NCI 5R01CA195732-03 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $348,844
Neuroblastoma 2018 NIBIB 1R01EB026291-01A1 Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors LI, SHULIN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $360,000
Neuroblastoma 2018 NCI 1R01CA219006-01A1 PARP-1 as a novel target for alpha-particle therapy in high-risk Neuroblastoma PRYMA, DANIEL UNIVERSITY OF PENNSYLVANIA PA $652,362
Neuroblastoma 2018 NICHD 5R03HD089190-02 Examining Signals That Sculpt Cranial Neural Crest Migration KULESA, PAUL STOWERS INSTITUTE FOR MEDICAL RESEARCH MO $82,500
Neuroblastoma 2018 NCI 1R01CA214912-01A1 Tumor and host markers of clinical outcomes after MIBG therapy in neuroblastoma DUBOIS, STEVEN DANA-FARBER CANCER INST MA $629,914
Neuroblastoma 2018 NCI 1R01CA215461-01A1 Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma CAPITINI, CHRISTIAN UNIVERSITY OF WISCONSIN-MADISON WI $347,078
Neuroblastoma 2018 NCI 5R35CA197078-04 Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome SONDEL, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $915,223
Neuroblastoma 2018 NINDS 5R01NS095411-04 Targeting Tumors with NF1 Loss SANCHEZ, YOLANDA DARTMOUTH COLLEGE NH $541,146
Neuroblastoma 2018 NCI 5P30CA125123-12 8013 Cancer Cell and Gene Therapy Program (Project-005) HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $66,213
Neuroblastoma 2018 NIGMS 5F32GM120956-03 Role of Ubiquitination in Neurocristopathies and Neural Crest-Derived Cancers MARK, KEVIN UNIVERSITY OF CALIFORNIA BERKELEY CA $61,174
Neuroblastoma 2018 NCI 5R35CA210030-03 Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer STEGMAIER, KIMBERLY DANA-FARBER CANCER INST MA $1,046,441
Neuroblastoma 2018 NCI 5R21CA219352-02 Role of m6A mRNA methylation in Neuroblastoma GREGORY, RICHARD BOSTON CHILDREN'S HOSPITAL MA $191,227
Neuroblastoma 2018 NCI 5R01CA207983-02 Exosomes in tumor cell-mesenchymal stromal cell interaction DECLERCK, YVES CHILDREN'S HOSPITAL OF LOS ANGELES CA $449,691
Neuroblastoma 2018 NIGMS 5R01GM066233-14 The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma WANG, JOANNE UNIVERSITY OF WASHINGTON WA $372,175
Neuroblastoma 2018 NCI 5R03CA212802-02 The role of JMJD6 in MYC-mediated neuroblastoma YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $89,750
Neuroblastoma 2018 NCI 1F31CA220844-01A1 Exploiting resistance mechanisms to RAS-MAPK inhibition in relapsed neuroblastoma COGGINS, GRACE UNIVERSITY OF PENNSYLVANIA PA $44,524
Neuroblastoma 2018 NCI 1R01CA217251-01A1 Alternate telomere maintenance mechanisms in high-risk neuroblastoma as prognostic indicators and therapeutic targets REYNOLDS, CHARLES TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $349,988
Neuroblastoma 2018 NCI 5U01CA217864-02 Integrating targeted and immunotherapy to treat genetically heterogeneous cancers WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $1,010,431
Neuroblastoma 2018 NCI 5R50CA211437-03 Revealing cancer metabolism via mass spectrometry and isotope tracers LU, WENYUN PRINCETON UNIVERSITY NJ $108,427
Neuroblastoma 2018 NIGMS 5SC3GM102050-05 Formulation of Fenretinide Nanoparticles for Enhanced Bioavailability BOSTANIAN, LEVON XAVIER UNIVERSITY OF LOUISIANA LA $106,384
Neuroblastoma 2018 NCI 5P01CA217959-02 5991 Targeting Evolving Therapy Resistance MOSSE, YAEL CHILDREN'S HOSP OF PHILADELPHIA PA $286,843
Neuroblastoma 2018 NCI 5P01CA217959-02 5992 Exploiting Therapeutic Vulnerabilities WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $270,796
Neuroblastoma 2018 NCI 5P01CA217959-02 5994 Targeting the Pro-tumorigenic Microenvironment DECLERCK, YVES CHILDREN'S HOSPITAL OF LOS ANGELES CA $284,892
Neuroblastoma 2018 NCI 5P01CA217959-02 5995 Enhancing the Potency and Durability  of Immunotherapies SEEGER, ROBERT CHILDREN'S HOSPITAL OF LOS ANGELES CA $521,774
Neuroblastoma 2018 NCI 5P01CA217959-02 5996 Administrative Core MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $95,762
Neuroblastoma 2018 NCI 5P01CA217959-02 5997 Clinical Trials and Translation MATTHAY, KATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $561,437
Neuroblastoma 2018 NCI 5P01CA217959-02 5998 Biostatics GROSHEN, SUSAN UNIVERSITY OF SOUTHERN CALIFORNIA CA $149,734
Neuroblastoma 2018 NCI 5R35CA220500-02 Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $1,032,000
Neuroblastoma 2018 NCI 2P30CA082103-19 5321 Pediatric Malignancies Program MATTHAY, KATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $86,469
Neuroblastoma 2018 NCI 5R01CA182526-05 Targeting Neuroblastoma with armed T cells LUM, LAWRENCE UNIVERSITY OF VIRGINIA VA $1
Neuroblastoma 2018 NCI 1R01CA229739-01 Development of small molecules to target KDM4B YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $410,606
Neuroblastoma 2018 NCI 1R21CA218764-01A1 Discovering adenosine kinase inhibitor targets in human neuroblastoma LAN, MICHAEL LSU HEALTH SCIENCES CENTER LA $158,775
Neuroblastoma 2018 NCI 1K08CA230223-01 Targeting the GPC2 oncoprotein with immune-based therapies in neuroblastoma BOSSE, KRISTOPHER CHILDREN'S HOSP OF PHILADELPHIA PA $202,195
Neuroblastoma 2018 NCI 1R21CA223300-01A1 Exploiting chemoimmunotherapy strategies with genetically-engineered gd T cells GOLDSMITH, KELLY EMORY UNIVERSITY GA $200,637
Neuroblastoma 2018 NCI 1R03CA230366-01 Discovering the genetic basis of neuroblastoma initiation and progression DISKIN, SHARON CHILDREN'S HOSP OF PHILADELPHIA PA $172,000
Neuroblastoma 2018 NCI 1R21CA216867-01A1 Novel ODC Inhibitor Phaseolotoxin in Neuroblastoma BACHMANN, ANDRE MICHIGAN STATE UNIVERSITY MI $193,750
Neuroblastoma 2018 NCI 3R01CA215452-02S1 Identifying and targeting oncogenic Myc enhancer control in pediatric tumors LIN, CHARLES BAYLOR COLLEGE OF MEDICINE TX $7,156
Neuroblastoma 2018 NCI 1R01CA227671-01A1 A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children ZHENG, PAN UNIVERSITY OF MARYLAND BALTIMORE MD $431,631
Neuroblastoma 2018 NCI 1F31CA232468-01 Metabolic and Effector Properties of invariant Natural Killer T cells in Neuroblastoma KHURANA, PRIYA UNIVERSITY OF PENNSYLVANIA PA $44,524
Neuroblastoma 2018 NCI 1F31CA225069-01A1 An integrative approach to identify neuroblastoma immunotherapeutic targets WEINER, AMBER UNIVERSITY OF PENNSYLVANIA PA $44,524
Neuroblastoma 2018 NCI 1U01CA232488-01 Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers WANG, RUONING RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $3,370,657
Neuroblastoma 2018 NCI 1U01CA232490-01 Combinations of Synergistic Bispecific Human Antibodies: A Novel Strategy for the Treatment of Neuroblastoma OLSON, JAMES FRED HUTCHINSON CANCER RESEARCH CENTER WA $2,200,000
Neuroblastoma 2018 NCI 1U01CA232491-01 Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway PACZESNY, SOPHIE INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $4,129,375
Neuroblastoma 2018 NCI 1U54CA232568-01 6269 Discovery and development of pediatric cancer antigen targets recognized by adaptive immune response SONDEL, PAUL CHILDREN'S HOSP OF PHILADELPHIA PA $93,800
Neuroblastoma 2018 NCI 3P30CA008748-52S2 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $2,734
Neuroblastoma 2018 NCI 3P30CA008748-52S1 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $21,114
Neuroblastoma 2018 NCI 1U2CCA233285-01 8213 Biospecimen Unit COLE, KRISTINA CHILDREN'S HOSP OF PHILADELPHIA PA $216,187
Neuroblastoma 2018 NCI 1U2CCA233285-01 8214 Characterization unit ZHANG, KUN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $1,558,895
Neuroblastoma 2018 NCI 3P30CA021765-39S1 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $8,413
Neuroblastoma 2018 NCI 3P30CA021765-39S2 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $3,681
Neuroblastoma 2018 NCI 261200800001E-132-0-142 OCG Data Coordinating Center HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $525,000
Neuroblastoma 2018 NCI 3P30CA138313-10S1 6380 INCLUSION OF CHILDREN IN CLINICAL RESEARCH KRAFT, ANDREW MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $9,253
Neuroblastoma 2018 NCI 3R01CA215452-02S2 Identifying and Targeting Onocgenic MYC Enhancer Control in Pediatric Tumors LIN, CHARLES BAYLOR COLLEGE OF MEDICINE TX $45,800
Neuroblastoma 2018 NICHD 1R13HD097893-01 2019 Neural Crest and Cranial Placodes GRC and GRS TRAINOR, PAUL GORDON RESEARCH CONFERENCES RI $6,000
Neuroblastoma 2018 NINDS 1R13HD097893-01 2019 Neural Crest and Cranial Placodes GRC and GRS TRAINOR, PAUL GORDON RESEARCH CONFERENCES RI $5,000
Neuroblastoma 2018 NIGMS 3R01GM066233-14S1 The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma WANG, JOANNE UNIVERSITY OF WASHINGTON WA $111,409
Neuroblastoma 2018 NCI 7R01CA215753-02 Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma FABBRI, MULLER UNIVERSITY OF HAWAII AT MANOA HI $340,118
Neuroblastoma 2018 NCI 7R01CA219024-02 Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance. FABBRI, MULLER UNIVERSITY OF HAWAII AT MANOA HI $262,816
Neuroblastoma 2018 NCI 7R01CA216394-02 Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis FREEMAN, KEVIN UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $347,700
Neuroblastoma 2018 NCI 3UM1CA097452-15S2 Pediatric Phase 1/Pilot Consortium WEIGEL, BRENDA CHILDREN'S HOSP OF PHILADELPHIA PA $600,000
Neuroblastoma 2018 NCI 4R00CA204593-03 Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer ALTMAN, BRIAN UNIVERSITY OF ROCHESTER NY $249,000
Neuroblastoma 2018 NCI 3P30CA008748-52S3 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $4,923
Neuroblastoma 2018 NCI 3P30CA125123-12S1 8013 Cancer Cell and Gene Therapy Program (Project-005) HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $4,755
Neuroblastoma 2018 NCI 3P30CA125123-12S2 8013 Cancer Cell and Gene Therapy Program (Project-005) HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $9,999
Neuroblastoma 2018 NCI 3P30CA008748-52S4 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $13,274
Neuroblastoma 2018 NCI 3P30CA093373-16S1 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $12,500
Neuroblastoma 2018 NCI 3P30CA093373-16S2 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $4,474
Neuroblastoma 2018 NCI 3P30CA093373-16S3 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $3,000
Neuroblastoma 2018 NCI 3P30CA093373-16S6 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $11,775
Neuroblastoma 2018 NCI 3P30CA093373-16S4 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $10,000
Neuroblastoma 2018 NCI 3P30CA093373-16S5 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $6,250
Neuroblastoma 2018 NCI 3P30CA082103-19S1 5321 Pediatric Malignancies Program MATTHAY, KATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $3,500
Neuroblastoma 2018 NCI 1ZIABC010390-19 Role of Neurotrophins in the Development of the Mammalian Nervous System TESSAROLLO, LINO NIH $848,710
Neuroblastoma 2018 NCI 1ZIABC010788-12 Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma THIELE, CAROL NIH $1,065,881
Neuroblastoma 2018 NCI 1ZIABC010789-12 Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma THIELE, CAROL NIH $573,937
Neuroblastoma 2018 NCI 1ZIABC010806-12 Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma KHAN, JAVED NIH $247,561
Neuroblastoma 2018 NCI 1ZIABC010891-11 Development of new antibody-based cancer therapies HO, MITCHELL NIH $1,849,077
Neuroblastoma 2018 NCI 1ZIABC010998-11 Identification of Novel Mutations In Pediatric Cancers KHAN, JAVED NIH $742,680
Neuroblastoma 2018 NCI 1ZIABC011197-10 Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells APPELLA, ETTORE NIH $821,973
Neuroblastoma 2018 NCI 1ZIABC011805-01 Defining the Mechanism of Action of Rigosertib in Pediatric Cancers YOHE, MARIELLE NIH $332,085
Neuroblastoma 2018 NCI 1ZIASC010366-18 Identification of Genes for Predicting Prognosis in Pediatric Cancers KHAN, JAVED NIH $247,561
Neuroblastoma 2018 NCI 1ZICBC011567-05 HiTIF Microscopy Core Facility PEGORARO, GIANLUCA NIH $1,153,191
Neuroblastoma 2018 NCI 1ZIEBC011516-06 Pediatric Oncology Branch Clinical Care and Education GLOD, JOHN NIH $4,881,326
Neuroblastoma 2018 NCI 1ZIABC011848-01 Preclinical Modelling and Therapeutic Development for Other Cancer Indications SHARAN, SHYAM NIH $158,825
Neuroblastoma 2018 NCI 3P30CA082103-19S2 5321 Pediatric Malignancies Program MATTHAY, KATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $8,603
Neuroblastoma 2018 NCI 3P30CA082103-19S3 5321 Pediatric Malignancies Program MATTHAY, KATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $10,743
Neuroblastoma 2018 NCI 3P30CA014089-43S1 5251 Core-009 FARNHAM, PEGGY UNIVERSITY OF SOUTHERN CALIFORNIA CA $2,030
Neuroblastoma 2018 NCI 3P30CA014089-43S1 8290 Tumor Microenvironment Research Program (Project-003) DECLERCK, YVES UNIVERSITY OF SOUTHERN CALIFORNIA CA $2,029


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer